Vape maker tried — and failed — to donate to major cancer group; engineered virus shows promise against breast cancer

Popular vape maker Elf Bar wanted to donate to the American Cancer Society. But the group doesn't want the money.

February 14, 2023 Check out STAT+

Sponsored By

To keep you even more up to date on cancer news and research, starting on Feb. 21, this newsletter will arrive in your inbox twice a week, on Tuesdays and Fridays.

PATRICK T. FALLON/AFP via Getty Images Vape maker Elf Bar wants to donate to the American Cancer Society, but it doesn't want tobacco money Popular vape maker Elf Bar wanted to donate to the American Cancer Society. But the group doesn't want the money. By Nicholas Florko STAT+ | Engineered virus shows promise against aggressive form of breast cancer In a small Phase 2 trial, using a tumor-infecting virus along with chemotherapy yielded better survival for triple-negative breast cancer. By Angus Chen STAT+ | A CAR-T from Bristol Myers benefits myeloma patients at earlier stage of care The CAR-T cancer therapy called Abecma reduced the risk of multiple myeloma relapse by half compared to standard treatment. By Adam Feuerstein Samuel Corum/Getty Images Opinion: State of the Union highlights America's awkward conversation on financing the development of new medicines Trying to put caps on medicine prices and trying to cure are contradictory policies that overlook the value of discovering new medicines. By MacKay Jimeson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser